Edition:
India

CRISPR Therapeutics AG (CRSP.OQ)

CRSP.OQ on NASDAQ Stock Exchange Global Market

43.98USD
25 Jun 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$43.98
Open
$43.50
Day's High
$44.91
Day's Low
$43.00
Volume
93,514
Avg. Vol
169,535
52-wk High
$66.26
52-wk Low
$22.23

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 0.33 -0.929
FY 2018 Dec '18 0.12 -0.920
Sep '18 0.56 -1.070
Jun '18 1.09 -0.819
Mar '18 1.36 -0.617
FY 2017 Dec '17 32.33 0.003
Sep '17 2.39 -0.616
Jun '17 3.58 -0.559
Mar '17 2.70 -0.541
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-19 8 2.38 7.50 0.00 5.50
Quarter Ending Sep-19 10 2.33 10.30 0.00 5.50
Year Ending Dec-19 10 5.17 15.30 0.00 22.12
Year Ending Dec-20 11 11.79 46.70 0.00 25.24
Earnings (per share)
Quarter Ending Jun-19 10 -0.92 -0.73 -1.08 -0.71
Quarter Ending Sep-19 12 -0.95 -0.78 -1.10 -0.73
Year Ending Dec-19 11 -3.86 -3.17 -4.66 -2.92
Year Ending Dec-20 13 -4.14 -2.51 -5.22 -3.51
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % 1,990.69 -- --
EPS (TTM) % -194.70 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for CRISPR Therapeutics AG

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 2.99 -0.56 99 --
13 Week 21.54 15.62 99 --
26 Week 0.05 -7.55 99 --
52 Week -- -- -- --
YTD -4.74 -16.34 82 --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 50.14%
# of Holders: 226
Total Shares Held: 26,531,278
3 Mo. Net Change: 3,875,836
# New Positions: 47
# Closed Positions: 29
# Increased Positions: 102
# Reduced Positions: 70
# Net Buyers: 32
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.